4th Quarter - Report

WILLIAMS AND JENSEN, PLLC for BAYER CORPORATION

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Chemicals/Chemical Industry CHM

Matters concerning safety and security at chemical plants.

LobbyistCovered position, as disclosed
GEORGE OLSEN —
ANTHONY J RODA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 1, the American Recovery and Reinvestment Act; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

LobbyistCovered position, as disclosed
JENNY DIJAMES —
JACK STEVEN HART —
SUSAN HIRSCHMANN —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), S. 501 (111th), S. 357 (111th), H.R. 3590 (111th), H.R. 1706 (111th), H.R. 1427 (111th), S. 1259 (111th), S. 1232 (111th), S. 369 (111th), H.R. 579 (111th), H.R. 3962 (111th), H.R. 573 (111th), S. 525 (111th), S. 1213 (111th), H.R. 3200 (111th), H.R. 1 (111th), H.R. 1548 (111th), S. 301 (111th), H.R. 1298 (111th)

Medicare/Medicaid MMM

Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009; Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Preemption Drug Gap Reduction Act of 2009; Medicare payment for diagnostic testing; and Medicare payment/coverage for telemedicine.

LobbyistCovered position, as disclosed
JENNY DIJAMES —
KARINA LYNCH —
ROBERT J MARTINEZ —
GEORGE OLSEN —
JOYCE A ROGERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 547 (111th), H.R. 904 (111th), H.R. 1725 (111th), S. 266 (111th), H.R. 684 (111th), S. 330 (111th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.